Three years ago, enterprise AI sales was straightforward -- or at least it appeared to be. Procurement teams were excited about AI. Budgets were being allocated. Pilot programs were being greenlighted. The conventional wisdom was that any AI company with a compelling demo and a credible founding team could get into enterprise accounts without too much friction.
That environment has changed substantially. Enterprise buyers are more sophisticated, more skeptical, and more demanding about proof points. The easy pilot has been replaced by extensive security review, legal scrutiny over data handling, and pressure for contractual commitments about model performance that would have been inconceivable in 2022. For founders building AI products today, understanding this new reality is essential -- and the generic enterprise SaaS playbooks that circulate in startup communities do not adequately address it.
This essay distills what we have observed across 40 portfolio companies navigating enterprise AI sales over the past two years. It is not a complete playbook, and the right tactics will vary by vertical and product category. But there are consistent patterns that distinguish companies that are closing enterprise contracts efficiently from those that are stuck in indefinite pilot phases or losing deals at the security review stage.
The Enterprise AI Buyer Has Changed
The first thing founders need to understand is that the enterprise AI buyer has fundamentally changed since 2022. The internal champion who used to be able to green-light a pilot with a corporate credit card and a six-figure discretionary budget now faces significantly more internal scrutiny. Chief information security officers, legal teams, data governance functions, and senior IT leadership have inserted themselves into the AI buying process in ways that were not common two years ago.
This is not unique to AI -- it mirrors how enterprise SaaS procurement evolved in the early 2010s when cloud adoption triggered security and compliance scrutiny that had not previously been applied to software purchases. But the pace of this evolution in AI has been faster, and the specific concerns are different in ways that require founders to adapt their sales process deliberately.
The three most common objections that stall enterprise AI deals in 2025 are:
Data governance and privacy concerns. "We cannot share customer data with a third-party AI model" is the most common procurement objection we hear from portfolio companies. Enterprises have become acutely aware of the risks of customer data appearing in training sets or being accessible to model providers, and even technically well-designed products that do not actually have these risks face this objection because enterprise buyers apply precautionary frameworks that may not be technically calibrated to the actual risk profile of the product.
Model reliability and auditability. "How do we explain this to our regulators?" is a question that comes from financial services, healthcare, and insurance companies in virtually every AI sales process. These industries have regulatory requirements around explainability, fairness, and auditability that do not map neatly to how most AI models work. Founders who have not developed clear answers to these questions before entering enterprise sales cycles will lose deals that should be closable.
Contractual liability for model outputs. Enterprise legal teams are pushing for contractual commitments about AI model performance that no AI company can reasonably make -- guarantees about accuracy, explicit liability clauses for incorrect outputs, and indemnification provisions that would expose the AI vendor to open-ended risk. Negotiating these provisions requires founders to understand what they are actually willing to commit to and what they are not, and to enter negotiations with clear positions rather than discovering their stance in the middle of a legal review process.
What Actually Closes Enterprise AI Deals
Against this more challenging backdrop, we have observed consistent patterns in the portfolio companies that are closing enterprise contracts efficiently. These patterns are not magic -- they are the result of deliberate choices about how to structure the sales process from the beginning.
Lead with specific ROI that the champion can defend internally. The era of AI demos that wow technical buyers but fail to generate financial justification is over for enterprise sales. Every deal we have seen close efficiently in the past eighteen months has a specific, quantified ROI calculation that the internal champion can present to their CFO. Not "AI will make your team more productive" but "this implementation will reduce manual review time by 60 percent, which translates to 12 FTEs of annual labor cost across your three largest business units."
This level of specificity requires more pre-sales work than most seed-stage founders want to invest before a deal is signed. But the companies that are winning enterprise contracts have accepted this reality and are investing in the customer discovery necessary to build credible ROI models before the first formal sales presentation.
Build a security evidence package before you need it. The single most common reason that enterprise AI deals stall in our portfolio is that the founding team is not prepared to navigate the security review process that every large enterprise now runs. Security reviews that should take two to four weeks are consuming three to six months because AI companies are iteratively discovering new requirements and scrambling to address them one by one.
The companies that navigate security reviews efficiently have built a comprehensive security evidence package proactively: SOC 2 Type II certification, detailed data processing agreements, network architecture documentation, model access controls, data retention policies, and breach notification protocols. This investment is expensive for a seed-stage company, but the cost of losing or indefinitely delaying enterprise deals is higher. We recommend portfolio companies pursue SOC 2 Type II immediately after their first enterprise design partnership, not after they have lost three deals at the security review stage.
Identify the IT champion, not just the business champion. Most seed-stage AI companies focus their early sales energy on the business buyer -- the VP or director who has the problem the product solves and the enthusiasm to champion it internally. This is necessary but not sufficient. The business champion's ability to close a deal is gated on whether they can bring IT leadership along. We have seen multiple deals where a highly motivated business champion lost internal momentum because they did not have a relationship with the CTO or VP of IT who ultimately needed to approve the vendor.
The tactical implication is that AI companies need a deliberate strategy for building relationships with IT stakeholders early in the enterprise sales cycle, not waiting until the IT objection surfaces in a late-stage procurement review.
Structure pilots for success, not just for a yes. Poorly structured pilots are one of the most common failure modes we see in enterprise AI sales. Pilots that lack clear success criteria, defined timelines, and explicit paths to conversion create indefinite evaluation periods that consume sales team resources without generating revenue. We have seen pilots run for 18 months with no contractual commitment and no conversion path because the original pilot agreement did not define what a successful outcome looked like or what the financial terms would be after the pilot.
The companies that are converting pilots to contracts efficiently are structuring pilots with explicit success metrics agreed upon before the pilot starts, a defined timeline (typically 90 days), and a contractual provision that automatically converts to a paid subscription if the success metrics are achieved. This framing requires more upfront negotiation but results in dramatically higher conversion rates and shorter overall sales cycles.
Vertical-Specific Observations
The patterns above apply broadly across enterprise AI categories, but there are specific dynamics worth noting in the three verticals where our portfolio has the deepest experience.
Healthcare. Healthcare AI sales cycles are the most complex and time-consuming of any vertical we track. HIPAA compliance, IRB requirements for certain applications, and the involvement of clinical leadership in buying decisions add layers of complexity that extend typical sales cycles by six to twelve months beyond what similar enterprise sales would require in other industries. Portfolio companies selling into healthcare need to budget for this complexity explicitly and build relationships with clinical champions who can navigate institutional approval processes -- not just IT or administrative buyers.
Financial Services. Financial services enterprises are increasingly willing to buy AI products, but the contractual requirements are more demanding than any other vertical. Model explainability, fair lending compliance, data residency requirements, and regulatory examination risk create a set of contractual demands that can consume enormous negotiation resources. Having outside counsel experienced with fintech vendor agreements is a prerequisite for selling into regulated financial institutions -- this is not something founders should attempt to navigate with general-purpose startup legal counsel.
Mid-Market. While most of this essay focuses on large enterprise dynamics, the mid-market (companies with 100 to 1,000 employees) represents a more tractable early market for many AI products. Mid-market buyers have the scale to generate meaningful contract values but operate with much shorter sales cycles, simpler procurement processes, and more agile decision-making structures than large enterprises. For seed-stage AI companies trying to build revenue traction quickly, a mid-market-first strategy often generates more useful learning, faster, than targeting large enterprises from day one.
The Organizational Implications
The enterprise AI sales motion we are describing requires a different organizational structure than what many seed-stage AI companies build initially. The technical-founder-does-sales model that works for early design partnerships tends to break down as the company tries to scale to 10 to 20 enterprise accounts, because the complexity of navigating security reviews, legal negotiations, and IT champion development simultaneously with product development and fundraising is more than any single founder can sustainably manage.
The inflection point for most of our portfolio companies comes around $500K to $1M ARR, when the complexity of the enterprise sales process demands a first dedicated enterprise account executive. The mistake we see repeatedly is founders hiring a first sales hire who is excellent at executing a well-defined sales process but not equipped to help design the process in the first place. At the seed stage, the first sales hire needs to be a combination of strategist, process builder, and tactical executor -- a profile that is more expensive and harder to recruit than a conventional enterprise AE.
We help portfolio companies think through this hiring decision carefully and have a network of enterprise AI sales leaders who have navigated these specific challenges that we tap for introductions when portfolio companies reach this inflection point.
What This Means for 2025 and Beyond
The enterprise AI market is maturing faster than most participants expected. The easy deals that characterized 2022 and early 2023 are gone. What is replacing them is a more rigorous, more demanding, and ultimately more sustainable market where companies that have invested in the infrastructure to navigate enterprise procurement -- security certifications, data governance documentation, regulatory compliance frameworks -- will have a systematic advantage over competitors who are still treating enterprise sales as a lightweight process.
This maturation is positive for the long-term health of the AI industry. It means that enterprise AI revenue, when it is generated, is based on real value delivery and real contractual commitments rather than the pilot-theater dynamics that consumed so much sales energy in the early years of AI product adoption. But it also means that founders who have not yet invested in the organizational capabilities and legal infrastructure to sell into enterprise accounts need to start that investment now, before they are facing a stalled pipeline.
Priya Anand is a General Partner at Orbit AI. She previously served as CRO at three enterprise software companies, building sales organizations from the ground up across products in AI, data, and analytics. This article represents her personal views based on observations across the Orbit AI portfolio.